Meiho University Institutional Repository:Item 987654321/3486
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 2876/3793 (76%)
Visitors : 3856392      Online Users : 535
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.meiho.edu.tw/ir/handle/987654321/3486


    Title: LINEZOLID INDUCED THROMBOCYTOPENIA IN A PATIENT WITH RENAL INSUFFICIENCY: A CASE REPORTAND A RETROSPECTIVE CASE STUDY
    Authors: JWu;CHWen;YTJang;HSChen
    Date: 2017-12-15
    Issue Date: 2017-12-15T09:10:29Z (UTC)
    Abstract: Linezolid is a new antimicrobial agent with a broad
    spectrum of activity against all clinically important gram positive
    bacteria, including methicillin resistant Staphylococcus aureus
    (MRSA) and vancomycin resistant enterococci (VRE). The incidence
    of linezolid induced thrombocytopenia was reported to be
    2.4% in phase III trials. Clearance of linezolid is not altered in
    patents with renal insufficiency and no dose adjustment is necessary.
    Therefore, linezolid is a suitable and reasonable drug of
    choice for patients with renal insufficiency who have MRSA or
    VRE infection. Moreover, renal insufficiency is also known to
    cause thrombocytopenia.
    Appears in Collections:[Department of Information Technology] Papers

    Files in This Item:

    File Description SizeFormat
    溫俊皓(part)EAHP 2015 abstractbook2016 (3).pdf46KbAdobe PDF1417View/Open


    View Licence

    All items in MUIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback